Patents by Inventor Nathan B. Dinces

Nathan B. Dinces has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bispecific reagents for AIDS therapy
    Patent number: 5897861
    Abstract: Bispecific molecules which react both with the high-affinity Fc.gamma. receptor (Fc.gamma.RI) of effector cells and with the human immunodeficiency virus (HIV), or component thereof are disclosed. Binding of these bispecific molecules to the Fc.gamma.RI is not blocked by the binding of the Fc region of IgG to that same receptor, as the bispecific molecules are specific for an epitope on the Fc.gamma.RI distinct from the Fc binding epitope. The bispecific molecules are useful for targeting human effector cells to a target on HIV. Also disclosed are methods of treating HIV infection using these bispecific molecules.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: April 27, 1999
    Assignee: Medarex, Inc.
    Inventors: Michael W. Fanger, Paul M. Guyre, Nathan B. Dinces